IRONWOOD PHARMACEUTICALS INC

By person

17 insiders · 18 transactions

9.8×

Thomas McCourt holds 9.8 times base salary in stock. $8.58M of shares against $867.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas McCourt last reported holding, valued at $4.52, the price Class A Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

DENNER ALEXANDER J

Director

—

$20.53M (2)

−$20.53M

9,512,490

$43.00M

−40.8%

Silver Ronald

PFO & PAO

—

$831.18K (4) scheduled

−$831.18K

755,250

$3.41M

+18.9%

MCCOURT Thomas A

Chief Executive Officer

—

$739.93K (2)

−$739.93K

1,898,838

$8.58M

+64.8%

John Minardo

Chief Legal Officer

—

$136.18K (2)

−$136.18K

500,498

$2.26M

+75.8%

Shetzline Michael

SVP, CMO, Head-Res&Drug

—

$121.59K (2)

−$121.59K

1,179,462

$5.33M

+30.9%

Gaskins Tammi L

Chief Commercial Officer

—

$100.30K (3)

−$100.30K

350,350

$1.58M

+42.9%

Martini Gregory S.

Chief Financial Officer

—

$81.89K (2)

−$81.89K

297,213

$1.34M

+250.7%

McHugh Julie

Director

—

$80.46K (1) scheduled

−$80.46K

250,749

$1.13M

+53.0%

Currie Mark G

Director

—

676,900

$3.06M

+19.1%

Emany Sravan Kumar

SVP, COO and CFO

—

309,572

$1.40M

−3.4%

Davis Andrew

SVP, Chief Business Officer

—

284,685

$1.29M

−1.8%

Duane Jon R

Director

—

253,820

$1.15M

+74.6%

Shepard Jay

Director

—

235,036

$1.06M

+85.7%

Kessler Marla L

Director

—

229,364

$1.04M

+89.7%

Dreyfus Andrew

Director

—

228,313

$1.03M

+24.5%

Moukheibir Catherine

Director

—

181,425

$820.04K

+148.7%

Silber Jeffrey

SVP, CMO, Head-Res&Drug

—

137,036

$619.40K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Silver Ronald

7 Jul 2026

PFO & PAO

Sold on a plan

127,890

$4.52

$578.06K

McHugh Julie

16 Jun 2026

Director

Sold on a plan

21,571

$3.73

$80.46K

DENNER ALEXANDER J

17 Mar 2026

Director

Sell indirect

5,800

$3.31

$19.20K

DENNER ALEXANDER J

17 Mar 2026

Director

Sell indirect

6,725,000

$3.05

$20.51M

Silver Ronald

24 Feb 2026

Principal Accounting Officer

Sell

12,621

$3.66

$46.19K

Martini Gregory S.

24 Feb 2026

Chief Financial Officer

Sell

11,457

$3.66

$41.93K

MCCOURT Thomas A

24 Feb 2026

Chief Executive Officer

Sell

103,526

$3.66

$378.91K

Gaskins Tammi L

24 Feb 2026

Chief Commercial Officer

Sell

11,239

$3.66

$41.13K

Shetzline Michael

24 Feb 2026

SVP, CMO, Head-Res&Drug

Sell

17,012

$3.66

$62.26K

John Minardo

24 Feb 2026

Chief Legal Officer

Sell

19,053

$3.66

$69.73K

Silver Ronald

23 Feb 2026

Principal Accounting Officer

Sell

11,552

$3.81

$44.01K

Martini Gregory S.

23 Feb 2026

Chief Financial Officer

Sell

10,487

$3.81

$39.96K

MCCOURT Thomas A

23 Feb 2026

Chief Executive Officer

Sell

94,757

$3.81

$361.02K

Gaskins Tammi L

23 Feb 2026

Chief Commercial Officer

Sell

10,287

$3.81

$39.19K

Shetzline Michael

23 Feb 2026

SVP, CMO, Head-Res&Drug

Sell

15,570

$3.81

$59.32K

John Minardo

23 Feb 2026

Chief Legal Officer

Sell

17,439

$3.81

$66.44K

Silver Ronald

5 Jan 2026

Principal Accounting Officer

Sold on a plan

35,416

$4.60

$162.91K

Gaskins Tammi L

17 Nov 2025

Chief Commercial Officer

Sell

6,016

$3.32

$19.97K

IRONWOOD PHARMACEUTICALS INC

By person

Individual transactions

What was left out